Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

New P2X4 receptor antagonist is active in models of neuropathic pain

March 16, 2012

Studies demonstrate various therapeutic applications for SEH inhibition

March 16, 2012

Anti-fibrillogenic agents designed via out-of-plane substitutions show therapeutic potential

March 16, 2012

Telaprevir improves hepatitis C therapy in HIV-1-coinfected patients

March 16, 2012

HIV peptide-loaded dendritic cells evaluated in DALIA trial

March 15, 2012

NME protects human bone marrow progenitor cells against radiation

March 15, 2012

Peptide inhibitor nanoparticles reduce beta-amyloid aggregation in preclinical study

March 15, 2012

New Trevena G protein-biased mu opioid receptor ligand has analgesic activity

March 14, 2012

GM-CSF-adjuvanted vaccine provides long-term protection in HIV model

March 14, 2012

Studies address suitability of allopregnanolone to treat Niemann-Pick disease type C

March 14, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...